New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
08:14 EDTBMRNBioMarin price target raised to $84 from $78 at Leerink
Leerink raised its price target for BioMarin shares to $84 after its physician survey indicated a more rapid uptake of Vimizim for Morquio syndrome than it had modeled. The firm keeps an Outperform rating on the stock.
News For BMRN From The Last 14 Days
Check below for free stories on BMRN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 8, 2014
07:15 EDTBMRNIBC Life Sciences to hold a conference
10th Annual Cell Line Development & Engineering Conference to be held in Berkeley, California on September 8-10.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use